Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Ant venom immunotherapy in Australia: the unmet need

Thumbnail Image

Date

2014

Authors

Mullins, Raymond
Brown, Simon GA

Journal Title

Journal ISSN

Volume Title

Publisher

Australasian Medical Association

Abstract

Jack jumper ant (JJA) venom allergy is an important cause of anaphylaxis in south-eastern Australia. The efficacy and real-world effectiveness of JJA venom immunotherapy (VIT) to prevent anaphylaxis in allergic patients are now well established, with an evidence base that is at least equivalent to that supporting VIT for allergy to other insect species. The tolerability and safety of JJA VIT are comparable with those of honeybee VIT.

Description

Keywords

Citation

URI

http://hdl.handle.net/1885/30815

Collections

ANU Research Publications

Source

Medical Journal of Australia

Type

Journal article

Book Title

Entity type

Access Statement

Open Access

License Rights

DOI

10.5694/mja13.00035

Restricted until

Downloads

File
Description
01_Mullins_Ant_venom_immunotherapy_in_2014.pdf (138.65 KB)

DSpace software copyright © 2002-2026 LYRASIS